drugset / Trial / NCT01301157
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is to evaluate the efficacy and safety of M518101 and the dose relationship among two doses of M518101 and placebo in male and female plaque psoriasis patients.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcipotriol | Small molecule | — | — |
| Subject | pefcalcitol | Small molecule | 25 ug | — |
| Subject | pefcalcitol | Small molecule | 50 ug | — |